BCLI
Brainstorm Cell Therapeutics Inc.Company with tickers: BCLI
CIK
1137883
CUSIP
10501E300
Shares Outstanding
11,034,775
Website
https://www.brainstorm-cell.com
Investor Relations
https://brainstorm-cell.com/investors/
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Peter Pitts | director | Appointed | 2026-05-28 |